Management of ALL in adults: 2024 ELN recommendations from a European expert panel
Nicola Gökbuget(Goethe University Frankfurt), Renato Bassan(Pittini Group (Italy)), Robin Foà(Sapienza University of Rome), Sabina Chiaretti(Sapienza University of Rome), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Michael Doubek(Central European Institute of Technology), Philippe Rousselot(Université Paris-Saclay), Oliver G. Ottmann(Cardiff University), Anita W. Rijneveld(Erasmus MC Cancer Institute), Giovanni Martinelli(University of Bologna), Nicolas Boissel(Inserm), Adele K. Fielding(New York Blood Center), Josep‐María Ribera(Universitat Autònoma de Barcelona), Dieter Hoelzer(Endokrinologikum), Hervé Dombret(University of London Institute in Paris), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Mathilde Hunault(Centre National de la Recherche Scientifique)
Cited by 120
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k